About the Authors

Joseph B. Margolick

Jmargol1@jhu.edu

Affiliation Department of Molecular Microbiology and Immunology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, United States of America

Linda Apuzzo

Affiliation Department of Molecular Microbiology and Immunology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, United States of America

Joel Singer

Affiliation CIHR Canadian HIV Trials Network, Vancouver, British Columbia, Canada

Hubert Wong

Affiliation CIHR Canadian HIV Trials Network, Vancouver, British Columbia, Canada

Terry Lee

Affiliation CIHR Canadian HIV Trials Network, Vancouver, British Columbia, Canada

Joel E. Gallant

Current address: Southwest CARE Center, Santa Fe, New Mexico, United States of America

Affiliation Department of Medicine, Johns Hopkins School of Medicine, Baltimore, Maryland, United States of America

Phillippe El-Helou

Affiliation Department of Medicine, McMaster University, Hamilton, Ontario Canada

Mona R. Loutfy

Affiliation Maple Leaf Medical Clinic, Toronto, Ontario, Canada

Anita Rachlis

Affiliation Sunnybrook Health Sciences, Toronto, Ontario, Canada

Christopher Fraser

Affiliation Cool Aid Community Health Center, Victoria, British Columbia, Canada

Kenneth Kasper

Affiliation Department of Medical Microbiology, University of Manitoba, Winnipeg, Manitoba, Canada

Cécile Tremblay

Affiliation Centre de recherché du Centre Hospitalier de l’ Université de Montréal, Montréal, Quebec, Canada

Harout Tossonian

Affiliation Vancouver Infectious Diseases Centre, Vancouver, British Columbia, Canada

Brian Conway

Affiliation Vancouver Infectious Diseases Centre, Vancouver, British Columbia, Canada

Competing Interests

The authors have read the journal's policy and one author of this manuscript has the following competing interest: Gilead Sciences, GlaxoSmithKline, Bristol-Myers Squibb, and Abbott Laboratories provided antiretroviral medications for this study and additional financial support was provided by Janssen Therapeutics. Gallant: AbbVie (research support), Bristol-Myers Squibb (research support and scientific advisory board), Gilead Sciences (research support and scientific advisory board), Janssen Therapeutics (research support and scientific advisory board), Merck & Co. (research support and scientific advisory board), Sangamo BioSciences (research support), ViiV Healthcare (research support and scientific advisory board). There are no patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.

Author Contributions

Conceived and designed the experiments: JM JS HW JG BC. Performed the experiments: JM LA JG PE-H ML AR CF KK CT HT BC. Analyzed the data: JS HW TL. Wrote the paper: JM LA JS HW TL JG PE-H ML AR CF KK CT HT BC.